Infiuss Health

Product Introduction

1. Definition: Infiuss Health is an AI-powered clinical research and precision medicine platform. Its core technology is the creation of "Digital Patient Twins"—dynamic, computational models that simulate individual human physiology and disease progression to predict real-world treatment outcomes.
2. Core Value Proposition: Infiuss Health exists to transform and accelerate clinical research by removing the biggest barriers in Randomized Controlled Trial (RCT) design. It provides a complete AI-powered ecosystem for clinical trial simulation, protocol optimization, and precision medicine, enabling researchers to predict patient response before a study begins, thereby reducing cost, time, and risk.

Main Features

1. Digital Patient Twin Engine: This is the foundational AI model that creates virtual patient replicas. It works by ingesting and unifying multi-modal health data—including EHR/EMR records, genomics, medical imaging, lab results, and wearable device streams—into a single, coherent patient profile. The system uses advanced machine learning and large language models (LLMs) trained on clinical data to simulate disease progression and forecast individual responses to specific interventions or trial protocols.
2. AI-Powered Clinical Trial Simulation (Probe Platform): This feature allows clinical researchers to run virtual trials. Users can input a proposed trial protocol, and the platform uses the aggregated Digital Patient Twins to simulate outcomes across a diverse, synthetic cohort. It provides insights on likely efficacy, potential adverse events, optimal dosing, and patient stratification strategies before any real-world patient is enrolled, de-risking trial design.
3. Enterprise-Grade Data Integration & Interoperability: The platform features robust, HIPAA-compliant connectors for seamless data aggregation from disparate healthcare IT systems. It supports industry standards like HL7 FHIR and DICOM for interoperability with EHRs, labs, and imaging archives. Data is encrypted in transit (TLS 1.3) and at rest (256-bit AES), with role-based access controls, audit trails, and certifications including SOC 2 Type II and ISO 27001, ensuring secure, real-time data synchronization.

Problems Solved

1. Pain Point: The high failure rate and excessive cost of clinical trials, often due to poor protocol design based on non-human data, difficulty in patient recruitment/retention, and unexpected human physiological responses.
2. Target Audience: Clinical Research Organizations (CROs), pharmaceutical and biotech research teams, academic medical center researchers, and healthcare systems engaged in precision medicine initiatives.
3. Use Cases: A pharmaceutical company can use Infiuss to simulate Phase II trial outcomes for a new oncology drug across a digital population with varied genetic markers, identifying the most responsive sub-group for a more efficient and targeted Phase III trial. A hospital system can create Digital Twins for chronic disease patients to predict COPD exacerbations and personalize management plans.

Unique Advantages

1. Differentiation: Unlike traditional clinical trial management software or basic data analytics platforms, Infiuss Health provides a predictive simulation layer. It moves beyond retrospective data analysis to prospective, AI-driven outcome forecasting, offering a "what-if" modeling environment for research that is unique in the market.
2. Key Innovation: The application of a "Digital Patient Twin" concept specifically for clinical research simulation. While digital twins are used in other industries, Infiuss's innovation lies in its focus on modeling human biological variability for trial design, its integration of diverse clinical data sources, and its deployment of specialized LLMs for clinical prediction tasks.

Frequently Asked Questions (FAQ)

1. What is a Digital Patient Twin in healthcare? A Digital Patient Twin is a comprehensive, AI-driven virtual model of an individual patient that integrates real-time data from electronic health records (EHR), genomics, wearables, and imaging. It is used to simulate health outcomes, predict disease progression, and personalize treatment plans and clinical trial protocols.
2. How does Infiuss Health improve clinical trial design? Infiuss Health improves clinical trial design by using its AI platform to simulate trial outcomes on Digital Patient Twins before the study begins. This allows researchers to optimize protocols, predict efficacy and safety signals, stratify the ideal patient population, and reduce the need for costly mid-trial amendments, significantly accelerating the research timeline.
3. Is patient data secure on the Infiuss platform? Yes, Infiuss Health is built with an enterprise-grade security-first approach. It is fully HIPAA and GDPR compliant, employs 256-bit AES encryption for data at rest and TLS 1.3 for data in transit, and features multi-factor authentication, role-based access controls, and holds SOC 2 Type II and ISO 27001 certifications to ensure data privacy and security.
4. What types of data sources can Infiuss Health integrate? The platform can integrate and unify data from a wide range of sources including hospital EHR/EMR systems, genetic sequencing reports, medical imaging archives (via DICOM), continuous data from wearable devices and IoT sensors, and traditional lab results, creating a holistic view for each Digital Patient Twin.
5. Who is the primary user of Infiuss Health's Probe platform? The primary users are clinical research professionals, including biostatisticians, clinical trial managers, medical directors at pharmaceutical companies and CROs, and principal investigators at research institutions who are responsible for designing, planning, and executing randomized controlled trials and precision medicine studies.